This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Activity Details

329 * Tue, 8/3/2010, 10:30 AM - 12:20 PM CC-302/303 (West)
The Design and Analysis of Crossover Trials: Some Recent Developments — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Byron Jones, Pfizer Inc.
Chair(s): Robb Muirhead, Statistical Scientist
10:35 AM Sample Size Re-estimation in Crossover Trials Adina Soaita, Pfizer Inc. ; Byron Jones, Pfizer Inc. ; Jerry J. Weaver, Pfizer Inc.
10:55 AM Scaled Average Bioequivalence for Highly Variable Drugs Scott Patterson, Pfizer Inc. ; Byron Jones, Pfizer Inc. ; Dieter Hauschke, University Medical Center Freiburg
11:15 AM Comparing Adaptive and Traditional Crossover Designs for Dose-Finding Trials James A. Bolognese, Cytel Inc. ; Nitin R. Patel, Cytel Inc. ; Byron Jones, Pfizer Inc.
11:35 AM The Use of Baseline Covariates in Cross-Over Studies Byron Jones, Pfizer Inc. ; Michael G. Kenward, London School of Hygiene and Tropical Medicine ; James Henry Roger, GlaxoSmithKline
11:55 AM Optimal Crossover Designs for PK Studies Sergei Leonov, GlaxoSmithKline ; Valerii Fedorov, GlaxoSmithKline ; Byron Jones, Pfizer Inc.
12:15 PM Floor Discussion

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.